Literature DB >> 15814818

Dementia of the Alzheimer's type and accelerated aging in Down syndrome.

D A Devenny1, J Wegiel, N Schupf, E Jenkins, W Zigman, S J Krinsky-McHale, W P Silverman.   

Abstract

This case study, of a woman with Down syndrome and dementia of the Alzheimer's type (DAT), follows the course of her decline over an 11-year period until death at age 57. Detailed neuropathological findings are also presented. This case illustrates features of premature aging that are typically associated with Down syndrome, and the progressive changes in memory and cognition that are usually associated with DAT. Although the subject's cardiovascular condition and thyroid disorder were treated, they may have contributed to the decline of her memory. This case shows the difficulty in diagnosing dementia in an individual with mental retardation who suffered comorbid episodes of depression and psychosis.

Entities:  

Mesh:

Year:  2005        PMID: 15814818     DOI: 10.1126/sageke.2005.14.dn1

Source DB:  PubMed          Journal:  Sci Aging Knowledge Environ        ISSN: 1539-6150


  21 in total

1.  Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade.

Authors:  Matthew G Bartley; Kristin Marquardt; Danielle Kirchhof; Heather M Wilkins; David Patterson; Daniel A Linseman
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.

Authors:  Sigan L Hartley; Benjamin L Handen; Darlynne Devenny; Iulia Mihaila; Regina Hardison; Patrick J Lao; William E Klunk; Peter Bulova; Sterling C Johnson; Bradley T Christian
Journal:  Neurobiol Aging       Date:  2017-06-02       Impact factor: 4.673

3.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

4.  Cognitive control and associated neural correlates in adults with spina bifida myelomeningocele.

Authors:  Ashley L Ware; Paulina A Kulesz; Jenifer Juranek; Paul T Cirino; Jack M Fletcher
Journal:  Neuropsychology       Date:  2017-02-16       Impact factor: 3.295

Review 5.  Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.

Authors:  Y Eugene Yu; Zhuo Xing; Catherine Do; Annie Pao; Eun Joon Lee; Sharon Krinsky-McHale; Wayne Silverman; Nicole Schupf; Benjamin Tycko
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

Review 6.  HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.

Authors:  Eugenio Barone; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2016-11-10       Impact factor: 7.376

7.  Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.

Authors:  Eleonore Bayen; Katherine L Possin; Yingjia Chen; Laurent Cleret de Langavant; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

8.  Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

Authors:  Sigan L Hartley; Benjamin L Handen; Darlynne A Devenny; Regina Hardison; Iulia Mihaila; Julie C Price; Annie D Cohen; William E Klunk; Marsha R Mailick; Sterling C Johnson; Bradley T Christian
Journal:  Brain       Date:  2014-07-02       Impact factor: 13.501

9.  Alzheimer's Disease in Down Syndrome.

Authors:  Elizabeth Head; David Powell; Brian T Gold; Frederick A Schmitt
Journal:  Eur J Neurodegener Dis       Date:  2012-12

10.  Vision deficits in adults with Down syndrome.

Authors:  Sharon J Krinsky-McHale; Wayne Silverman; James Gordon; Darlynne A Devenny; Nancy Oley; Israel Abramov
Journal:  J Appl Res Intellect Disabil       Date:  2013-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.